Insiders · Profile

Brady James Aloysius

Director at Xeris Biopharma. Filing since 30 Mar 2026. CIK 0001916987

Company

Date

Role

Action

Shares

Amount

Of holding

XERS Xeris Biopharma Holdings, Inc.

30 Mar 2026

Director

Sold on a plan

10,834

$60.04K

10.8%

1 decision on file.